License to produce Lutetium-177 for clinical trials
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Showing 1401 - 1420 of 1706 results
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Dr Anne Hellstedt has been appointed Director of ANSTO’s Innovation Precinct.
The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.
A neutron reflectometer for vertical samples.
Unique opportunity to contribute to the long term conservation of Australia’s most iconic landmark: The Sydney Harbour Bridge.
Beamtime guide on the SAX / WAXS beamline at the Australian Synchrotron.
Moving earth in the search for dark matter: laboratory construction underway at mine site.
The Australian Government recently announced $30 million to design a new world-leading nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, and replace and an ageing facility.
A site for the National Radioactive Waste Management Facility has been acquired, with the new facility to be built near the town of Kimba on the South Australian Eyre Peninsula.
Young and mid-career ANSTO scientists and engineers have been featured in the latest issue of Careers with STEM that highlights careers in nuclear science.
ANSTO is working with government partners to ensure that radioactivity in drinking water supplied to Aboriginal communities is at levels considered safe for consumption.
A research paper that shares early results from an IAEA funded project evaluates the state of medical physics in diagnostic radiology and image-guided procedures in the Asia-Pacific region has been published in Physical and Engineering Sciences in Medicine.